Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-15-055817
Filing Date
2015-09-21
Accepted
2015-09-21 21:23:32
Documents
1
Period of Report
2015-09-18

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v420661_4.html 4  
1 OWNERSHIP DOCUMENT v420661_4.xml 4 4529
  Complete submission text file 0001144204-15-055817.txt   6136
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Issuer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CAPRICOR, INC. 8840 WILSHIRE BLVD, 2ND FLOOR BEVERLY HILLS CA 90211
Business Address
Ascheim Deborah (Reporting) CIK: 0001649531 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34058 | Film No.: 151118397